Usefulness of an Initial Single Intravenous Immunoglobulin Infusion with Delayed Use of Aspirin against Kawasaki Disease Relapse: A Single-Center Retrospective Study

2019 ◽  
Vol 06 (01) ◽  
pp. 18-24
Author(s):  
Toshimasa Nakada ◽  
Keyword(s):  
Retrospective Study ◽  
Kawasaki Disease ◽  
Intravenous Immunoglobulin ◽  
Disease Relapse ◽  
Single Center

Infliximab for Intravenous Immunoglobulin Resistance in Kawasaki Disease: A Retrospective Study

2011 ◽  
Vol 158 (4) ◽  
pp. 644-649.e1 ◽  
Author(s):  
Mary Beth Son ◽  
Kimberlee Gauvreau ◽  
Jane C. Burns ◽  
Elena Corinaldesi ◽  
Adriana H. Tremoulet ◽  
...  
Keyword(s):  
Retrospective Study ◽  
Kawasaki Disease ◽  
Intravenous Immunoglobulin ◽  
Intravenous Immunoglobulin Resistance

scholarly journals Cardiovascular outcomes following Kawasaki disease in Moscow, Russia: A single center experience

2018 ◽  
Vol 2017 (3) ◽  
Author(s):  
Galina Lyskina ◽  
Olga Bockeria ◽  
Olga Shirinsky ◽  
Alena Torbyak ◽  
Anna Leontieva ◽  
...  
Keyword(s):  
Retrospective Study ◽  
Coronary Artery ◽  
Kawasaki Disease ◽  
Moscow Region ◽  
Single Center ◽  
Coronary Artery Aneurysms ◽  
Delayed Treatment ◽  
Giant Aneurysms ◽  
Single Center Experience ◽  
Over Time

Background: Awareness of Kawasaki disease (KD) is emerging in Russia but the diagnosis is still often missed. Methods: This is a retrospective study of 303 children with KD who received care at a single center in Moscow over the period from 2004 to 2016. Results: Overall, coronary artery aneurysms were documented in 91 (30,0%) of 303 patients and transient ectasia in 40 (13,2%). Intracoronary thrombi were found in 12 of 15 patients with giant aneurysms and in 3 patients with medium-sized aneurysms. Conclusion: The patients with KD in the Moscow region had typical features of the disease described in the literature but the proportion of patients with coronary artery aneurysms was higher than reported from other countries. We assume that this is due to delayed treatment, which has gradually improved over time. Increased awareness of KD in Russia is critical to ensure timely diagnosis and treatment. 

Malattia di Kawasaki: quale dose di immunoglobuline nei bambini grandi?

2020 ◽  
Vol 23 (9) ◽  
pp. 231-233
Author(s):  
Lorenzo Mambelli ◽  
Alessandra Iacono ◽  
Giovanna Rametta ◽  
Federico Marchetti
Keyword(s):  
Retrospective Study ◽  
Kawasaki Disease ◽  
Intravenous Immunoglobulin ◽  
Treatment Effects ◽  
Ivig Treatment ◽  
Japanese Children ◽  
Ivig Resistance ◽  
Coronary Aneurysms ◽  
Significant Difference ◽  
Randomised Controlled

In a retrospective study conducted on a population of Japanese children with a weight ≥ 25 kg and with Kawasaki disease, no significant difference has been observed for the onset of coronary aneurysms, intravenous immunoglobulin (IVIg) resistance, duration of the hospitalisation and adverse treatment effects among the groups treated with 2 g/kg and 1 g/kg doses of IVIg. New randomised controlled studies are desirable to check the most appropriate IVIg dose for old children, also considering the cortisone treatment in association with the IVIg treatment firstly.

Sign in / Sign up

Export Citation Format

Share Document